985 published verifications avg. score 4.7/10 329 rated true or mostly true 629 rated false or misleading
“Having sex at least once a week produces measurable improvements in physical and mental health outcomes.”
Weekly sexual activity is associated with some better mental health markers in certain populations, but the claim overstates the evidence by using causal language ("produces") when the research is largely observational and correlational. A major systematic review flags contradictory findings, confounding bias, and population-specific effects. Physical health benefits are inconsistently supported — some longitudinal data actually links higher sexual frequency to increased cardiovascular risk in older men. The evidence does not support a blanket causal claim across both physical and mental health.
“The bacterium Prevotella copri is classified as a pathogen.”
Prevotella copri is not formally classified as a pathogen by any authoritative taxonomic or regulatory body. The gold-standard bacterial nomenclature registry LPSN assigns it to Risk Group 1, meaning it is "unlikely to cause human disease." While certain strains have shown disease associations — particularly with rheumatoid arthritis — the scientific literature consistently describes P. copri as a commensal or "pathobiont" with strain-dependent effects, not a pathogen. The claim conflates pathogenic potential in specific contexts with a formal species-wide classification that does not exist.
“New archaeological findings indicate that Mohenjo-daro is older than previously established dating estimates.”
Recent media reports do cite 2025–2026 radiocarbon dates pushing Mohenjo-daro's origins to ~3300 BC, but no primary excavation report, lab data, or peer-reviewed publication has been produced to substantiate these claims. The two supporting sources appear non-independent, and the claim risks conflating broader Indus Valley antiquity evidence (e.g., from Bhirrana) with Mohenjo-daro specifically. Presenting these unverified reports as established "archaeological findings" materially overstates the current evidence base.
“Red yeast rice lowers cholesterol levels in humans.”
Clinical evidence strongly supports that red yeast rice preparations containing meaningful amounts of monacolin K lower LDL and total cholesterol in humans, with meta-analyses of randomized controlled trials showing 15–25% LDL reductions. However, the claim requires an important caveat: monacolin K content varies widely across commercial products, and in the U.S., products with substantial monacolin K face FDA restrictions as unapproved drugs. Not all retail red yeast rice supplements will reliably produce cholesterol-lowering effects.
“Men have a significantly higher sex drive than women, on average.”
The best available evidence — including a large-scale 2022 meta-analysis of over 620,000 individuals — consistently finds that men report higher average sex drive than women, with a medium-to-large effect size that remains significant after adjusting for response bias. However, the observed gap is partly driven by behavioral measures like masturbation frequency, and sociocultural factors such as sexual stigma and gendered scripts may suppress women's reported desire. The claim is directionally accurate but omits these important measurement and contextual nuances.
“The oral contraceptive pill universally reduces sexual desire in all women who take it.”
The evidence decisively contradicts this claim. Systematic reviews show approximately 84.6% of oral contraceptive users report no change in sexual desire, and about 12% actually report an increase — only a small minority experience a decrease. While reduced libido is a real, documented side effect for some women, the claim's absolute language — "universally" and "all women" — is unsupported by any credible source. The pill's effects on desire are highly variable and individual.
“Use of the oral contraceptive pill causes long-term or permanent infertility after discontinuation.”
Overwhelming medical evidence directly contradicts this claim. The World Health Organization, systematic reviews, and large cohort studies all confirm that oral contraceptive use — regardless of duration — does not cause long-term or permanent infertility, with fertility returning promptly after discontinuation. Some women may experience temporary cycle irregularity, but this is a short-term adjustment, not infertility. The sources cited in support of the claim are either low-authority, commercially conflicted, or internally self-contradictory.
“Consumption of walnuts can improve sperm quality in humans.”
Peer-reviewed randomized controlled trials consistently show that walnut consumption produces statistically significant improvements in measurable sperm parameters including motility, vitality, and morphology. The evidence firmly supports the claim as stated — about sperm quality, not fertility outcomes. However, no large-scale study has confirmed these improvements translate to higher pregnancy or live-birth rates, and the primary RCT studied men on a Western-style diet, limiting generalizability.
“High-protein diets do not cause kidney damage in people with healthy kidneys.”
The best available evidence — including a major systematic review and meta-analysis — shows that high-protein diets have not been demonstrated to harm kidney function in healthy adults over studied timeframes. However, the claim's absolute phrasing ("do not cause kidney damage") overstates what the science can confirm. Most supporting trials are short-to-medium term, long-term effects remain uncertain, and some observational data and mechanistic concerns (hyperfiltration, kidney stones) complicate a categorical safety guarantee.
“A blood test developed by researchers at the University of East Anglia can detect early-stage dementia with 79% accuracy.”
The 79% accuracy figure is real but significantly mischaracterized. UEA researchers developed a preliminary machine-learning model using six gut-derived blood metabolites that classifies participants across three study groups — healthy, mild cognitive impairment (MCI), and impaired — with 79% accuracy. This is not a validated clinical blood test, and MCI is a precursor state, not equivalent to "early-stage dementia." Even UEA-affiliated coverage describes the work as research that "could pave the way" for a future test, not a deployable diagnostic tool.
“Purchasing 1,000 copies of a book is sufficient to qualify it for the New York Times Best Seller List.”
No credible evidence supports the idea that 1,000 purchased copies can land a book on the New York Times Best Seller List. Every available source places the minimum threshold at roughly 3,000–5,000 copies sold per week, depending on category and competition. The NYT also uses a proprietary methodology that actively flags or discounts strategic bulk purchases, meaning that buying 1,000 copies in a single transaction would likely not even be fully counted toward list qualification.
“Women are more emotionally driven than men in decision-making contexts.”
The scientific evidence does not support the broad claim that women are more emotionally driven than men in decision-making. Peer-reviewed meta-analyses and empirical studies show that sex differences in emotional influence on decisions are small, task-specific, and inconsistent in direction — with some research finding men more susceptible to emotional spillover in financial decisions. The claim relies on conflating emotional sensitivity or neural activation with emotion-dominated choices, a logical leap that neuroscience research explicitly cautions against.
“Common cosmetic ingredients, when used at regulatory-approved doses, are toxic to human health.”
The evidence does not support the assertion that common cosmetic ingredients are toxic at regulatory-approved doses. Regulatory frameworks in the EU, Canada, and (post-MoCRA) the U.S. set approved doses well below observed adverse-effect thresholds, typically with 100x safety margins. Sources cited in support describe associations at unspecified exposure levels, regulatory gaps, or scientific uncertainty about long-term cumulative effects — none demonstrate toxicity at approved doses under normal use. The claim conflates hazard identification with actual risk at regulated exposure levels.
“Dietary intervention is more effective than medication at reversing coronary artery disease.”
While intensive lifestyle programs have demonstrated some angiographic regression of coronary artery disease, no rigorous head-to-head trial has compared dietary intervention against modern statin or PCSK9-inhibitor therapy for CAD reversal. The landmark Lifestyle Heart Trial (n=48) lacked a medication arm and tested a multi-component program—not diet alone. High-quality reviews indicate that combining lifestyle changes with medication produces the best outcomes, undermining the claim that diet is "more effective" than drugs.
“Parallel universes exist.”
No credible scientific source supports the assertion that parallel universes are a confirmed reality. The most authoritative sources — including the Stanford Encyclopedia of Philosophy and peer-reviewed literature — consistently describe parallel universes as a feature of certain theoretical interpretations (such as the Many-Worlds Interpretation) that lack direct empirical evidence. The strongest observational candidate, bubble-collision signatures in the cosmic microwave background, has not reached statistical significance. Stating their existence as fact conflates mathematical possibility with physical confirmation.
“Eliminating carbohydrates from the diet causes fat loss regardless of total caloric intake.”
Controlled metabolic-ward studies consistently show that when calories are held equal, eliminating carbohydrates does not produce superior fat loss — and in some cases, fat restriction outperforms carbohydrate restriction. While low-carb diets can aid weight loss in real-world settings, this effect is largely driven by spontaneous calorie reduction through appetite suppression, not a calorie-independent mechanism. The claim's absolute framing — "regardless of total caloric intake" — contradicts the established scientific principle that a caloric deficit is required for fat loss.
“Insulin resistance prevents fat loss in humans.”
The absolute claim that insulin resistance "prevents" fat loss is not supported by the evidence. High-authority mechanistic studies show insulin resistance preserves antilipolytic signaling, making fat loss harder — but multiple clinical studies demonstrate that insulin-resistant individuals do lose fat through caloric restriction and exercise, sometimes at rates equal to or exceeding non-insulin-resistant groups. The accurate statement is that insulin resistance impedes or complicates fat loss, not that it categorically blocks it.
“Elevated cortisol levels do not directly prevent fat loss in humans.”
This claim oversimplifies a highly context-dependent biological relationship. While cortisol can stimulate fat mobilization under certain acute conditions, peer-reviewed evidence shows that under chronic elevation — when insulin is typically co-elevated — cortisol promotes fat storage via lipoprotein lipase activation and reduces basal lipolysis. The blanket assertion that elevated cortisol "does not directly prevent fat loss" omits these critical mechanistic distinctions, leaving readers with a materially incomplete picture.
“Market-moving financial rumors spread on social media measurably increase short-term stock market volatility.”
A broad, multi-market evidence base spanning 2015–2026 confirms that market-moving financial rumors on social media are associated with measurable increases in short-term stock volatility. Studies using GARCH models, rumor indices, and intraday analyses across Chinese, South African, U.S., and U.K. markets consistently find statistically significant effects. However, the relationship is stronger for negative rumors, more pronounced in retail-dominated markets, and complicated by reverse causality — high volatility can itself drive social media activity. These caveats are material but do not negate the core claim.
“A declassified Central Intelligence Agency document reveals the existence of a cancer cure that has been suppressed.”
The declassified memo discusses 1950 Soviet lab work; it does not document a proven cancer cure, nor was it hidden—files have been publicly available for years. No credible evidence supports a suppressed, definitive cure.